Showing results (61-70 of 862) with videos related to
Sort By:
Pageof 87
CNS Spectrums|October 1, 2014
Clozapine: is now the time for more clinicians to adopt this orphan?Stephen M StahlCNS Spectrums|December 6, 2017
Neuronal traffic signals in tardive dyskinesia: not enough "stop" in the motor striatumStephen M StahlCNS Spectrums|October 3, 2017
Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypesStephen M StahlCNS Spectrums|October 1, 2019
Dextromethorphan/Bupropion: A Novel Oral NMDA (N-methyl-d-aspartate) Receptor Antagonist with Multimodal ActivityStephen M StahlJournal of Neural Transmission. Supplementum|January 1, 1988
Applications of new drug delivery technologies to Parkinson's disease and dopaminergic agentsS M StahlCNS Spectrums|March 29, 2014
Mechanism of action of the SPARI vilazodone: serotonin 1A partial agonist and reuptake inhibitorStephen M StahlCNS Spectrums|October 1, 2016
Parkinson's disease psychosis as a serotonin-dopamine imbalance syndromeStephen M StahlCNS Spectrums|March 9, 2017
Mixed-up about how to diagnose and treat mixed features in major depressive episodesStephen M StahlPsychopharmacology Bulletin|January 1, 1992
Serotonin neuroscience discoveries usher in a new era of novel drug therapies for psychiatryS M StahlThe Journal of Clinical Psychiatry|November 6, 2002
Independent actions on fear circuits may lead to therapeutic synergy for anxiety when combining serotonergic and GABAergic agentsStephen M StahlPageof 87